| Corona Remedies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544644 |
NSE Symbol : CORONA |
P/E(TTM) : 63.96 |
|
ISIN Demat : INE02ZQ01018 |
Div & Yield% : 0.45 |
EPS(TTM) : 34.62 |
|
Book Value(₹) : 121.97 |
Market Cap(₹Cr) : 13,542.68 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 422.43 | 353.09 | 342.42 | 361.13 | 346.54 | 293.69 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 422.43 | 353.09 | 342.42 | 361.13 | 346.54 | 293.69 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.15 | 4.11 | 2.24 | 2.27 | 2.02 | 1.42 |
| Total Income | 425.58 | 357.20 | 344.66 | 363.40 | 348.56 | 295.11 |
| Total Expenditure | 329.30 | 291.07 | 278.36 | 282.66 | 276.76 | 239.47 |
| PBIDT | 96.28 | 66.13 | 66.30 | 80.74 | 71.80 | 55.64 |
| Interest | 2.69 | 1.38 | 1.66 | 1.93 | 1.99 | 2.20 |
| PBDT | 93.59 | 64.75 | 64.64 | 78.81 | 69.81 | 53.44 |
| Depreciation | 13.24 | 10.29 | 9.45 | 9.20 | 8.92 | 10.04 |
| Tax | 18.38 | 4.23 | 17.10 | 15.85 | 14.30 | 9.24 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.87 | 5.18 | -3.16 | 1.61 | 0.19 | 2.82 |
| Reported Profit After Tax | 60.10 | 45.05 | 41.25 | 52.15 | 46.40 | 31.34 |
| Extra-ordinary Items | 0.00 | 0.00 | -13.18 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 60.10 | 45.05 | 54.43 | 52.15 | 46.40 | 31.34 |
| EPS (Unit Curr.) | 9.83 | 7.37 | 6.74 | 8.53 | 7.59 | 5.12 |
| EPS (Adj) (Unit Curr.) | 9.83 | 7.37 | 6.74 | 8.53 | 7.59 | 5.12 |
| Calculated EPS (Unit Curr.) | 9.83 | 7.37 | 6.74 | 8.53 | 7.59 | 5.12 |
| Calculated EPS (Adj) (Unit Curr.) | 9.83 | 7.37 | 6.74 | 8.53 | 7.59 | 5.12 |
| Calculated EPS (Ann.) (Unit Curr.) | 39.31 | 29.46 | 26.98 | 34.11 | 30.35 | 20.50 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 39.31 | 29.46 | 26.98 | 34.11 | 30.35 | 20.50 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 61.16 | 61.16 | 61.16 | 61.16 | 61.16 | 61.16 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 22.79 | 18.73 | 19.36 | 22.36 | 20.72 | 18.95 |
| PBDTM(%) | 22.16 | 18.34 | 18.88 | 21.82 | 20.14 | 18.20 |
| PATM(%) | 14.23 | 12.76 | 12.05 | 14.44 | 13.39 | 10.67 |
